DIFFERENTIAL MODULATION OF 5-HYDROXYTRYPTAMINE1D BINDING-SITES BY GTP AND GTPGAMMAS

被引:6
作者
HARRINGTON, MA [1 ]
PEROUTKA, SJ [1 ]
机构
[1] STANFORD UNIV,MED CTR,DEPT NEUROL,H-3160,STANFORD,CA 94305
关键词
G-protein; GTPgammaS; Serotonin-1D receptor;
D O I
10.1016/0006-8993(90)91217-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Incubation of bovine caudate membranes with 10-4M GTP results in a competitive inhibition of 5-hydroxytryptamine1D (5-HT1D) receptor binding sites labeled by [3H]5-HT. By contrast, incubation of bovine caudate membranes with 10-4M GTPgammaS, a non-hydrolyzable analog of GTP, results in a decrease in both the apparent affinity (Kd) and density (Bmax) of 5-HT1D binding sites. The (Kd) is increased by 67 ± 8%, (P < 0.01, n = 12) while the Bmax is reduced by 52 ± 10% in comparison with control values (P < 0.05, n = 12). Pre-incubation studies indicate that GTPgammaS-induced changes in 5-HT1D receptors are persistent and time-dependent. These results indicate that GTPgammaS induces non-competitive changes in 5-HT1D receptor-G-protein interactions that are reflected as a decrease in the affinity and density of binding sites labeled by [3H]5-HT. © 1990.
引用
收藏
页码:172 / 174
页数:3
相关论文
共 18 条
[11]   5-HT1D RECEPTOR-MEDIATED INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY IN CALF SUBSTANTIA NIGRA [J].
HOYER, D ;
SCHOEFFTER, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (01) :145-147
[12]  
KATADA T, 1984, J BIOL CHEM, V259, P3586
[13]  
KATADA T, 1984, J BIOL CHEM, V259, P3568
[14]   CA-2(+)-GUANINE NUCLEOTIDE INTERACTIONS IN BRAIN MEMBRANES .1. MODULATION OF CENTRAL 5-HYDROXYTRYPTAMINE RECEPTORS IN THE RAT [J].
MALLAT, M ;
HAMON, M .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (01) :151-161
[15]  
PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P700
[16]   NUCLEOTIDE INTERACTIONS WITH 5-HT1A BINDING-SITES DIRECTLY LABELED BY [H-3] 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN ([H-3]-8-OH-DPAT) [J].
SCHLEGEL, JR ;
PEROUTKA, SJ .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (12) :1943-1949
[17]  
SCHOEFFTER P, 1988, N-S ARCH PHARMACOL, V337, P602
[18]  
SILLS MA, 1984, MOL PHARMACOL, V26, P10